Bromperidol

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Bromperidol
Accession Number
DB12401
Type
Small Molecule
Groups
Approved, Investigational
Description

Bromperidol has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders, among others.

Structure
Thumb
Synonyms
Not Available
External IDs
R 11,333 / R-11333
Categories
UNII
LYH6F7I22E
CAS number
10457-90-6
Weight
Average: 420.322
Monoisotopic: 419.08962
Chemical Formula
C21H23BrFNO2
InChI Key
RKLNONIVDFXQRX-UHFFFAOYSA-N
InChI
InChI=1S/C21H23BrFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2
IUPAC Name
4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one
SMILES
OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteractionDrug group
2,5-Dimethoxy-4-ethylamphetamineBromperidol may decrease the stimulatory activities of 2,5-Dimethoxy-4-ethylamphetamine.Experimental, Illicit
2,5-Dimethoxy-4-ethylthioamphetamineBromperidol may decrease the stimulatory activities of 2,5-Dimethoxy-4-ethylthioamphetamine.Experimental
3,4-MethylenedioxyamphetamineBromperidol may decrease the stimulatory activities of 3,4-Methylenedioxyamphetamine.Experimental, Illicit
4-Bromo-2,5-dimethoxyamphetamineBromperidol may decrease the stimulatory activities of 4-Bromo-2,5-dimethoxyamphetamine.Experimental, Illicit
7-NitroindazoleThe risk or severity of adverse effects can be increased when 7-Nitroindazole is combined with Bromperidol.Experimental
AcepromazineThe risk or severity of adverse effects can be increased when Acepromazine is combined with Bromperidol.Approved, Vet Approved
AceprometazineThe risk or severity of adverse effects can be increased when Aceprometazine is combined with Bromperidol.Approved
AcetaminophenThe serum concentration of Bromperidol can be increased when it is combined with Acetaminophen.Approved
AdipiplonThe risk or severity of adverse effects can be increased when Adipiplon is combined with Bromperidol.Investigational
AgomelatineThe risk or severity of adverse effects can be increased when Agomelatine is combined with Bromperidol.Approved, Investigational
AlaproclateThe risk or severity of adverse effects can be increased when Bromperidol is combined with Alaproclate.Experimental
AlfaxaloneThe risk or severity of adverse effects can be increased when Alfaxalone is combined with Bromperidol.Vet Approved
AlfentanilThe risk or severity of adverse effects can be increased when Alfentanil is combined with Bromperidol.Approved, Illicit
AllopregnanoloneThe risk or severity of adverse effects can be increased when Allopregnanolone is combined with Bromperidol.Investigational
AlmotriptanThe risk or severity of adverse effects can be increased when Almotriptan is combined with Bromperidol.Approved, Investigational
AlphacetylmethadolThe risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Bromperidol.Experimental, Illicit
AlphaprodineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Alphaprodine.Illicit
AlprazolamThe risk or severity of adverse effects can be increased when Alprazolam is combined with Bromperidol.Approved, Illicit, Investigational
AmikacinThe risk or severity of adverse effects can be increased when Bromperidol is combined with Amikacin.Approved, Investigational, Vet Approved
AmiodaroneThe serum concentration of Bromperidol can be increased when it is combined with Amiodarone.Approved, Investigational
AmisulprideBromperidol may increase the antipsychotic activities of Amisulpride.Approved, Investigational
AmitriptylineThe risk or severity of adverse effects can be increased when Amitriptyline is combined with Bromperidol.Approved
AmlodipineThe serum concentration of Bromperidol can be increased when it is combined with Amlodipine.Approved
AmobarbitalThe risk or severity of adverse effects can be increased when Amobarbital is combined with Bromperidol.Approved, Illicit
AmoxapineThe risk or severity of adverse effects can be increased when Amoxapine is combined with Bromperidol.Approved
AmperozideThe risk or severity of adverse effects can be increased when Amperozide is combined with Bromperidol.Experimental
AmphetamineBromperidol may decrease the stimulatory activities of Amphetamine.Approved, Illicit, Investigational
AripiprazoleThe risk or severity of adverse effects can be increased when Aripiprazole is combined with Bromperidol.Approved, Investigational
ArticaineThe risk or severity of adverse effects can be increased when Articaine is combined with Bromperidol.Approved
AsenapineThe risk or severity of adverse effects can be increased when Asenapine is combined with Bromperidol.Approved
AzaperoneThe risk or severity of adverse effects can be increased when Azaperone is combined with Bromperidol.Investigational, Vet Approved
AzelastineBromperidol may increase the central nervous system depressant (CNS depressant) activities of Azelastine.Approved
BaclofenThe risk or severity of adverse effects can be increased when Baclofen is combined with Bromperidol.Approved
BarbitalThe risk or severity of adverse effects can be increased when Barbital is combined with Bromperidol.Illicit
BenperidolThe risk or severity of adverse effects can be increased when Bromperidol is combined with Benperidol.Approved, Investigational
BenzphetamineBromperidol may decrease the stimulatory activities of Benzphetamine.Approved, Illicit
Benzyl alcoholThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Bromperidol.Approved
BepridilThe serum concentration of Bromperidol can be increased when it is combined with Bepridil.Approved, Withdrawn
BrexpiprazoleThe risk or severity of adverse effects can be increased when Brexpiprazole is combined with Bromperidol.Approved, Investigational
BrimonidineBrimonidine may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.Approved
BromazepamThe risk or severity of adverse effects can be increased when Bromazepam is combined with Bromperidol.Approved, Illicit, Investigational
BromisovalThe risk or severity of adverse effects can be increased when Bromperidol is combined with Bromisoval.Experimental
BromocriptineThe risk or severity of adverse effects can be increased when Bromocriptine is combined with Bromperidol.Approved, Investigational
BrompheniramineThe risk or severity of adverse effects can be increased when Brompheniramine is combined with Bromperidol.Approved
BrotizolamThe risk or severity of adverse effects can be increased when Brotizolam is combined with Bromperidol.Approved, Investigational, Withdrawn
BupivacaineThe risk or severity of adverse effects can be increased when Bupivacaine is combined with Bromperidol.Approved, Investigational
BuprenorphineBromperidol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.Approved, Illicit, Investigational, Vet Approved
BupropionThe risk or severity of adverse effects can be increased when Bromperidol is combined with Bupropion.Approved
BuspironeThe risk or severity of adverse effects can be increased when Buspirone is combined with Bromperidol.Approved, Investigational
ButabarbitalThe risk or severity of adverse effects can be increased when Butabarbital is combined with Bromperidol.Approved, Illicit
ButacaineThe risk or severity of adverse effects can be increased when Butacaine is combined with Bromperidol.Vet Approved
ButalbitalThe risk or severity of adverse effects can be increased when Butalbital is combined with Bromperidol.Approved, Illicit
ButambenThe risk or severity of adverse effects can be increased when Butamben is combined with Bromperidol.Approved, Withdrawn
ButethalThe risk or severity of adverse effects can be increased when Butethal is combined with Bromperidol.Approved, Illicit
ButorphanolThe risk or severity of adverse effects can be increased when Butorphanol is combined with Bromperidol.Approved, Illicit, Vet Approved
CabergolineThe risk or severity of adverse effects can be increased when Cabergoline is combined with Bromperidol.Approved
CaffeineThe serum concentration of Bromperidol can be increased when it is combined with Caffeine.Approved
CanertinibThe risk or severity of adverse effects can be increased when Canertinib is combined with Bromperidol.Investigational
CarbamazepineThe risk or severity of adverse effects can be increased when Carbamazepine is combined with Bromperidol.Approved, Investigational
CarbinoxamineThe risk or severity of adverse effects can be increased when Carbinoxamine is combined with Bromperidol.Approved
CarfentanilThe risk or severity of adverse effects can be increased when Carfentanil is combined with Bromperidol.Illicit, Investigational, Vet Approved
CarisoprodolThe risk or severity of adverse effects can be increased when Carisoprodol is combined with Bromperidol.Approved
CarvedilolThe serum concentration of Bromperidol can be increased when it is combined with Carvedilol.Approved, Investigational
CetirizineThe risk or severity of adverse effects can be increased when Cetirizine is combined with Bromperidol.Approved
Chloral hydrateThe risk or severity of adverse effects can be increased when Chloral hydrate is combined with Bromperidol.Approved, Illicit, Investigational, Vet Approved
ChlordiazepoxideThe risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Bromperidol.Approved, Illicit, Investigational
ChloroprocaineThe risk or severity of adverse effects can be increased when Chloroprocaine is combined with Bromperidol.Approved
ChlorphenamineThe risk or severity of adverse effects can be increased when Chlorphenamine is combined with Bromperidol.Approved
ChlorphentermineBromperidol may decrease the stimulatory activities of Chlorphentermine.Illicit, Withdrawn
ChlorpromazineThe risk or severity of adverse effects can be increased when Chlorpromazine is combined with Bromperidol.Approved, Investigational, Vet Approved
ChlorprothixeneThe risk or severity of adverse effects can be increased when Chlorprothixene is combined with Bromperidol.Approved, Investigational, Withdrawn
ChlorzoxazoneThe risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Bromperidol.Approved
CinchocaineThe risk or severity of adverse effects can be increased when Cinchocaine is combined with Bromperidol.Approved, Vet Approved
CitalopramThe risk or severity of adverse effects can be increased when Bromperidol is combined with Citalopram.Approved
ClemastineThe risk or severity of adverse effects can be increased when Clemastine is combined with Bromperidol.Approved, Investigational
ClidiniumThe risk or severity of adverse effects can be increased when Clidinium is combined with Bromperidol.Approved
ClindamycinThe risk or severity of adverse effects can be increased when Bromperidol is combined with Clindamycin.Approved, Vet Approved
ClobazamThe risk or severity of adverse effects can be increased when Clobazam is combined with Bromperidol.Approved, Illicit
clomethiazoleThe risk or severity of adverse effects can be increased when clomethiazole is combined with Bromperidol.Investigational
ClomipramineThe risk or severity of adverse effects can be increased when Clomipramine is combined with Bromperidol.Approved, Investigational, Vet Approved
ClonazepamThe risk or severity of adverse effects can be increased when Clonazepam is combined with Bromperidol.Approved, Illicit
ClonidineThe risk or severity of adverse effects can be increased when Clonidine is combined with Bromperidol.Approved
ClopenthixolThe risk or severity of adverse effects can be increased when Bromperidol is combined with Clopenthixol.Experimental
ClorazepateThe risk or severity of adverse effects can be increased when Clorazepate is combined with Bromperidol.Approved, Illicit
ClothiapineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Clothiapine.Experimental
ClozapineThe risk or severity of adverse effects can be increased when Clozapine is combined with Bromperidol.Approved
CocaineThe risk or severity of adverse effects can be increased when Cocaine is combined with Bromperidol.Approved, Illicit
CodeineThe risk or severity of adverse effects can be increased when Codeine is combined with Bromperidol.Approved, Illicit
CyclizineThe risk or severity of adverse effects can be increased when Cyclizine is combined with Bromperidol.Approved
CyclobenzaprineThe risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Bromperidol.Approved
CyclopropaneThe risk or severity of adverse effects can be increased when Bromperidol is combined with Cyclopropane.Experimental
CyclosporineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Cyclosporine.Approved, Investigational, Vet Approved
CyproheptadineThe risk or severity of adverse effects can be increased when Cyproheptadine is combined with Bromperidol.Approved
DantroleneThe risk or severity of adverse effects can be increased when Dantrolene is combined with Bromperidol.Approved, Investigational
DapiprazoleThe risk or severity of adverse effects can be increased when Dapiprazole is combined with Bromperidol.Approved
DapoxetineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Dapoxetine.Investigational
DeramciclaneThe risk or severity of adverse effects can be increased when Deramciclane is combined with Bromperidol.Investigational
DesfluraneThe risk or severity of adverse effects can be increased when Desflurane is combined with Bromperidol.Approved
DesipramineThe risk or severity of adverse effects can be increased when Desipramine is combined with Bromperidol.Approved, Investigational
DesloratadineThe risk or severity of adverse effects can be increased when Desloratadine is combined with Bromperidol.Approved, Investigational
DesvenlafaxineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Desvenlafaxine.Approved, Investigational
DetomidineThe risk or severity of adverse effects can be increased when Detomidine is combined with Bromperidol.Vet Approved
DeutetrabenazineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Deutetrabenazine.Approved, Investigational
DexbrompheniramineThe risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Bromperidol.Approved
DexmedetomidineThe risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Bromperidol.Approved, Vet Approved
DexniguldipineThe serum concentration of Bromperidol can be increased when it is combined with Dexniguldipine.Experimental
DextroamphetamineBromperidol may decrease the stimulatory activities of Dextroamphetamine.Approved, Illicit
DextromethorphanThe risk or severity of adverse effects can be increased when Dextromethorphan is combined with Bromperidol.Approved
DextromoramideThe risk or severity of adverse effects can be increased when Dextromoramide is combined with Bromperidol.Experimental, Illicit
DextropropoxypheneThe risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Bromperidol.Approved, Illicit, Investigational, Withdrawn
DexverapamilThe serum concentration of Bromperidol can be increased when it is combined with Dexverapamil.Experimental
DezocineThe risk or severity of adverse effects can be increased when Dezocine is combined with Bromperidol.Approved, Investigational
DiazepamThe risk or severity of adverse effects can be increased when Diazepam is combined with Bromperidol.Approved, Illicit, Investigational, Vet Approved
Diethyl etherThe risk or severity of adverse effects can be increased when Bromperidol is combined with Diethyl ether.Experimental
DiethylpropionBromperidol may decrease the stimulatory activities of Diethylpropion.Approved, Illicit
DifenoxinThe risk or severity of adverse effects can be increased when Difenoxin is combined with Bromperidol.Approved, Illicit
DihydrocodeineThe risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Bromperidol.Approved, Illicit
DihydroergotamineThe risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Bromperidol.Approved, Investigational
DihydroetorphineThe risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Bromperidol.Experimental, Illicit
DihydromorphineThe risk or severity of adverse effects can be increased when Dihydromorphine is combined with Bromperidol.Experimental, Illicit
DiltiazemThe serum concentration of Bromperidol can be increased when it is combined with Diltiazem.Approved, Investigational
DimenhydrinateThe risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Bromperidol.Approved
DiphenhydramineThe risk or severity of adverse effects can be increased when Diphenhydramine is combined with Bromperidol.Approved, Investigational
DiphenoxylateThe risk or severity of adverse effects can be increased when Diphenoxylate is combined with Bromperidol.Approved, Illicit
DixyrazineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Dixyrazine.Experimental
DoramectinThe risk or severity of adverse effects can be increased when Doramectin is combined with Bromperidol.Vet Approved
DotarizineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Dotarizine.Investigational
DoxazosinThe serum concentration of Bromperidol can be increased when it is combined with Doxazosin.Approved
DoxepinThe risk or severity of adverse effects can be increased when Doxepin is combined with Bromperidol.Approved, Investigational
DoxylamineDoxylamine may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.Approved, Vet Approved
DPDPEThe risk or severity of adverse effects can be increased when DPDPE is combined with Bromperidol.Experimental
DronabinolDronabinol may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.Approved, Illicit
DroperidolDroperidol may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.Approved, Vet Approved
DrotebanolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Bromperidol.Experimental, Illicit
DuloxetineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Duloxetine.Approved
DyclonineThe risk or severity of adverse effects can be increased when Dyclonine is combined with Bromperidol.Approved
EcgonineThe risk or severity of adverse effects can be increased when Ecgonine is combined with Bromperidol.Experimental, Illicit
EcopipamThe risk or severity of adverse effects can be increased when Ecopipam is combined with Bromperidol.Investigational
EfavirenzThe risk or severity of adverse effects can be increased when Efavirenz is combined with Bromperidol.Approved, Investigational
EletriptanThe risk or severity of adverse effects can be increased when Eletriptan is combined with Bromperidol.Approved, Investigational
EltanoloneThe risk or severity of adverse effects can be increased when Eltanolone is combined with Bromperidol.Investigational
EmopamilThe serum concentration of Bromperidol can be increased when it is combined with Emopamil.Experimental
EnfluraneThe risk or severity of adverse effects can be increased when Enflurane is combined with Bromperidol.Approved, Investigational, Vet Approved
EntacaponeThe risk or severity of adverse effects can be increased when Entacapone is combined with Bromperidol.Approved, Investigational
EperisoneThe risk or severity of adverse effects can be increased when Bromperidol is combined with Eperisone.Approved, Investigational
Ergoloid mesylateThe risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Bromperidol.Approved
ErgonovineThe risk or severity of adverse effects can be increased when Ergonovine is combined with Bromperidol.Approved
ErgotamineThe risk or severity of adverse effects can be increased when Ergotamine is combined with Bromperidol.Approved
EscitalopramThe risk or severity of adverse effects can be increased when Bromperidol is combined with Escitalopram.Approved, Investigational
EstazolamThe risk or severity of adverse effects can be increased when Estazolam is combined with Bromperidol.Approved, Illicit
EszopicloneThe risk or severity of adverse effects can be increased when Eszopiclone is combined with Bromperidol.Approved, Investigational
EthanolBromperidol may increase the central nervous system depressant (CNS depressant) activities of Ethanol.Approved
EthchlorvynolThe risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Bromperidol.Approved, Illicit, Withdrawn
EthosuximideThe risk or severity of adverse effects can be increased when Ethosuximide is combined with Bromperidol.Approved
EthotoinThe risk or severity of adverse effects can be increased when Ethotoin is combined with Bromperidol.Approved
Ethyl carbamateThe risk or severity of adverse effects can be increased when Ethyl carbamate is combined with Bromperidol.Withdrawn
Ethyl chlorideThe risk or severity of adverse effects can be increased when Bromperidol is combined with Ethyl chloride.Approved, Experimental, Investigational
Ethyl loflazepateThe risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Bromperidol.Approved, Illicit
EthylmorphineThe risk or severity of adverse effects can be increased when Ethylmorphine is combined with Bromperidol.Approved, Illicit
EtidocaineThe risk or severity of adverse effects can be increased when Etidocaine is combined with Bromperidol.Approved
EtifoxineThe risk or severity of adverse effects can be increased when Etifoxine is combined with Bromperidol.Investigational, Withdrawn
EtizolamThe risk or severity of adverse effects can be increased when Etizolam is combined with Bromperidol.Approved
EtomidateThe risk or severity of adverse effects can be increased when Etomidate is combined with Bromperidol.Approved
EtoperidoneThe risk or severity of adverse effects can be increased when Bromperidol is combined with Etoperidone.Withdrawn
EtorphineThe risk or severity of adverse effects can be increased when Etorphine is combined with Bromperidol.Illicit, Vet Approved
EzogabineThe risk or severity of adverse effects can be increased when Ezogabine is combined with Bromperidol.Approved, Investigational
FelbamateThe risk or severity of adverse effects can be increased when Felbamate is combined with Bromperidol.Approved
FelodipineThe serum concentration of Bromperidol can be increased when it is combined with Felodipine.Approved, Investigational
FencamfamineThe risk or severity of adverse effects can be increased when Fencamfamine is combined with Bromperidol.Approved, Illicit, Withdrawn
FentanylThe risk or severity of adverse effects can be increased when Fentanyl is combined with Bromperidol.Approved, Illicit, Investigational, Vet Approved
FexofenadineThe risk or severity of adverse effects can be increased when Fexofenadine is combined with Bromperidol.Approved, Investigational
FlibanserinThe risk or severity of adverse effects can be increased when Flibanserin is combined with Bromperidol.Approved, Investigational
FluanisoneThe risk or severity of adverse effects can be increased when Bromperidol is combined with Fluanisone.Experimental
FludiazepamThe risk or severity of adverse effects can be increased when Fludiazepam is combined with Bromperidol.Approved, Illicit
FlunarizineThe risk or severity of adverse effects can be increased when Flunarizine is combined with Bromperidol.Approved
FlunitrazepamThe risk or severity of adverse effects can be increased when Flunitrazepam is combined with Bromperidol.Approved, Illicit
FluoxetineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Fluoxetine.Approved, Vet Approved
FlupentixolThe risk or severity of adverse effects can be increased when Flupentixol is combined with Bromperidol.Approved, Investigational, Withdrawn
FluphenazineThe risk or severity of adverse effects can be increased when Fluphenazine is combined with Bromperidol.Approved
FlurazepamThe risk or severity of adverse effects can be increased when Flurazepam is combined with Bromperidol.Approved, Illicit, Investigational
FluspirileneThe risk or severity of adverse effects can be increased when Fluspirilene is combined with Bromperidol.Approved, Investigational
Fluticasone propionateThe risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Bromperidol.Approved
FluvoxamineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Fluvoxamine.Approved, Investigational
FospropofolThe risk or severity of adverse effects can be increased when Fospropofol is combined with Bromperidol.Approved, Illicit, Investigational
FrovatriptanThe risk or severity of adverse effects can be increased when Frovatriptan is combined with Bromperidol.Approved, Investigational
GabapentinThe risk or severity of adverse effects can be increased when Gabapentin is combined with Bromperidol.Approved, Investigational
Gabapentin EnacarbilThe risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Bromperidol.Approved, Investigational
GallopamilThe serum concentration of Bromperidol can be increased when it is combined with Gallopamil.Investigational
Gamma Hydroxybutyric AcidThe risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Bromperidol.Approved, Illicit, Investigational
GepefrineBromperidol may decrease the stimulatory activities of Gepefrine.Experimental
GepironeThe risk or severity of adverse effects can be increased when Gepirone is combined with Bromperidol.Investigational
GlutethimideThe risk or severity of adverse effects can be increased when Glutethimide is combined with Bromperidol.Approved, Illicit
GlyburideThe serum concentration of Bromperidol can be increased when it is combined with Glyburide.Approved
GlycerinThe serum concentration of Bromperidol can be increased when it is combined with Glycerin.Approved, Investigational
GuanfacineThe risk or severity of adverse effects can be increased when Guanfacine is combined with Bromperidol.Approved, Investigational
HalazepamThe risk or severity of adverse effects can be increased when Halazepam is combined with Bromperidol.Approved, Illicit, Withdrawn
HaloperidolThe risk or severity of adverse effects can be increased when Haloperidol is combined with Bromperidol.Approved
HalothaneThe risk or severity of adverse effects can be increased when Halothane is combined with Bromperidol.Approved, Vet Approved
HeroinThe risk or severity of adverse effects can be increased when Heroin is combined with Bromperidol.Approved, Illicit, Investigational
HexobarbitalThe risk or severity of adverse effects can be increased when Hexobarbital is combined with Bromperidol.Approved
HydrocodoneBromperidol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.Approved, Illicit
HydromorphoneThe risk or severity of adverse effects can be increased when Hydromorphone is combined with Bromperidol.Approved, Illicit
HydroxyamphetamineBromperidol may decrease the stimulatory activities of Hydroxyamphetamine.Approved
HydroxyzineHydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.Approved
IbuprofenThe serum concentration of Bromperidol can be increased when it is combined with Ibuprofen.Approved
IloperidoneThe risk or severity of adverse effects can be increased when Iloperidone is combined with Bromperidol.Approved
ImipramineThe risk or severity of adverse effects can be increased when Imipramine is combined with Bromperidol.Approved
IndalpineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Indalpine.Investigational, Withdrawn
IndiplonThe risk or severity of adverse effects can be increased when Bromperidol is combined with Indiplon.Investigational
Iofetamine I-123Bromperidol may decrease the stimulatory activities of Iofetamine I-123.Approved
IsocarboxazidThe therapeutic efficacy of Bromperidol can be increased when used in combination with Isocarboxazid.Approved
IsofluraneThe risk or severity of adverse effects can be increased when Isoflurane is combined with Bromperidol.Approved, Vet Approved
IsradipineThe serum concentration of Bromperidol can be increased when it is combined with Isradipine.Approved, Investigational
KetamineThe risk or severity of adverse effects can be increased when Ketamine is combined with Bromperidol.Approved, Vet Approved
KetazolamThe risk or severity of adverse effects can be increased when Ketazolam is combined with Bromperidol.Approved
KetobemidoneThe risk or severity of adverse effects can be increased when Ketobemidone is combined with Bromperidol.Approved, Investigational
LamotrigineThe risk or severity of adverse effects can be increased when Lamotrigine is combined with Bromperidol.Approved, Investigational
LevetiracetamThe risk or severity of adverse effects can be increased when Levetiracetam is combined with Bromperidol.Approved, Investigational
LevobupivacaineThe risk or severity of adverse effects can be increased when Levobupivacaine is combined with Bromperidol.Approved, Investigational
LevocabastineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Levocabastine.Approved, Investigational
LevocetirizineThe risk or severity of adverse effects can be increased when Levocetirizine is combined with Bromperidol.Approved
LevodopaThe risk or severity of adverse effects can be increased when Levodopa is combined with Bromperidol.Approved
Levomethadyl AcetateThe risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Bromperidol.Approved, Investigational
LevomilnacipranThe risk or severity of adverse effects can be increased when Bromperidol is combined with Levomilnacipran.Approved, Investigational
LevorphanolThe risk or severity of adverse effects can be increased when Levorphanol is combined with Bromperidol.Approved
LidocaineThe serum concentration of Bromperidol can be increased when it is combined with Lidocaine.Approved, Vet Approved
LinezolidThe risk or severity of adverse effects can be increased when Linezolid is combined with Bromperidol.Approved, Investigational
LisdexamfetamineBromperidol may decrease the stimulatory activities of Lisdexamfetamine.Approved, Investigational
Lithium cationLithium may increase the neurotoxic activities of Bromperidol.Experimental
LofentanilThe risk or severity of adverse effects can be increased when Lofentanil is combined with Bromperidol.Illicit
LofexidineThe therapeutic efficacy of Bromperidol can be increased when used in combination with Lofexidine.Approved, Investigational
LomerizineThe serum concentration of Bromperidol can be increased when it is combined with Lomerizine.Experimental
LoperamideThe serum concentration of Bromperidol can be increased when it is combined with Loperamide.Approved
LoprazolamThe risk or severity of adverse effects can be increased when Bromperidol is combined with Loprazolam.Experimental
LoratadineThe risk or severity of adverse effects can be increased when Loratadine is combined with Bromperidol.Approved, Investigational
LorazepamThe risk or severity of adverse effects can be increased when Lorazepam is combined with Bromperidol.Approved
LorcaserinThe risk or severity of adverse effects can be increased when Lorcaserin is combined with Bromperidol.Approved
LormetazepamThe risk or severity of adverse effects can be increased when Bromperidol is combined with Lormetazepam.Approved
LosartanThe serum concentration of Bromperidol can be increased when it is combined with Losartan.Approved
LoxapineThe risk or severity of adverse effects can be increased when Loxapine is combined with Bromperidol.Approved
LurasidoneThe risk or severity of adverse effects can be increased when Lurasidone is combined with Bromperidol.Approved, Investigational
Magnesium carbonateThe risk or severity of adverse effects can be increased when Bromperidol is combined with Magnesium carbonate.Approved, Investigational
Magnesium citrateThe risk or severity of adverse effects can be increased when Bromperidol is combined with Magnesium citrate.Approved
Magnesium hydroxideThe risk or severity of adverse effects can be increased when Bromperidol is combined with Magnesium hydroxide.Approved, Investigational
Magnesium sulfateThe therapeutic efficacy of Bromperidol can be increased when used in combination with Magnesium sulfate.Approved, Investigational, Vet Approved
Magnesium TrisilicateThe risk or severity of adverse effects can be increased when Bromperidol is combined with Magnesium Trisilicate.Approved
MaprotilineThe risk or severity of adverse effects can be increased when Maprotiline is combined with Bromperidol.Approved, Investigational
MebicarThe risk or severity of adverse effects can be increased when Bromperidol is combined with Mebicar.Experimental
MeclizineThe risk or severity of adverse effects can be increased when Meclizine is combined with Bromperidol.Approved
MedazepamThe risk or severity of adverse effects can be increased when Bromperidol is combined with Medazepam.Experimental
MedetomidineThe risk or severity of adverse effects can be increased when Medetomidine is combined with Bromperidol.Vet Approved
MelatoninThe risk or severity of adverse effects can be increased when Melatonin is combined with Bromperidol.Approved, Nutraceutical, Vet Approved
MelperoneThe risk or severity of adverse effects can be increased when Melperone is combined with Bromperidol.Approved, Investigational
MephedroneBromperidol may decrease the stimulatory activities of Mephedrone.Investigational
MephentermineBromperidol may decrease the stimulatory activities of Mephentermine.Approved
MepivacaineThe risk or severity of adverse effects can be increased when Mepivacaine is combined with Bromperidol.Approved, Vet Approved
MeprobamateThe risk or severity of adverse effects can be increased when Meprobamate is combined with Bromperidol.Approved, Illicit
MeptazinolThe risk or severity of adverse effects can be increased when Bromperidol is combined with Meptazinol.Experimental
MequitazineBromperidol may increase the arrhythmogenic activities of Mequitazine.Approved
MesoridazineThe risk or severity of adverse effects can be increased when Mesoridazine is combined with Bromperidol.Approved, Investigational
MetaxaloneThe risk or severity of adverse effects can be increased when Metaxalone is combined with Bromperidol.Approved
MethadoneThe risk or severity of adverse effects can be increased when Methadone is combined with Bromperidol.Approved
Methadyl AcetateThe risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Bromperidol.Approved, Illicit
MethamphetamineBromperidol may decrease the stimulatory activities of Methamphetamine.Approved, Illicit
MethapyrileneThe risk or severity of adverse effects can be increased when Methapyrilene is combined with Bromperidol.Withdrawn
MethaqualoneThe risk or severity of adverse effects can be increased when Methaqualone is combined with Bromperidol.Illicit, Withdrawn
MethocarbamolThe risk or severity of adverse effects can be increased when Methocarbamol is combined with Bromperidol.Approved, Vet Approved
MethohexitalThe risk or severity of adverse effects can be increased when Methohexital is combined with Bromperidol.Approved
MethotrimeprazineBromperidol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.Approved, Investigational
MethoxyfluraneThe risk or severity of adverse effects can be increased when Methoxyflurane is combined with Bromperidol.Approved, Investigational, Vet Approved
MethoxyphenamineBromperidol may decrease the stimulatory activities of Methoxyphenamine.Experimental
MethsuximideThe risk or severity of adverse effects can be increased when Methsuximide is combined with Bromperidol.Approved
MethylecgonineThe risk or severity of adverse effects can be increased when Methylecgonine is combined with Bromperidol.Experimental
MethylphenidateThe risk or severity of adverse effects can be increased when Bromperidol is combined with Methylphenidate.Approved, Investigational
MethylphenobarbitalThe risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Bromperidol.Approved
MetoclopramideThe risk or severity of adverse effects can be increased when Metoclopramide is combined with Bromperidol.Approved, Investigational
MetyrosineThe risk or severity of adverse effects can be increased when Metyrosine is combined with Bromperidol.Approved
MibefradilThe serum concentration of Bromperidol can be increased when it is combined with Mibefradil.Investigational, Withdrawn
MiconazoleThe serum concentration of Bromperidol can be increased when it is combined with Miconazole.Approved, Investigational, Vet Approved
MidazolamThe risk or severity of adverse effects can be increased when Midazolam is combined with Bromperidol.Approved, Illicit
MidomafetamineBromperidol may decrease the stimulatory activities of Midomafetamine.Experimental, Illicit, Investigational
MilnacipranThe risk or severity of adverse effects can be increased when Bromperidol is combined with Milnacipran.Approved, Investigational
MinocyclineMinocycline may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.Approved, Investigational
MirtazapineBromperidol may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.Approved
MMDABromperidol may decrease the stimulatory activities of MMDA.Experimental, Illicit
MoclobemideThe risk or severity of adverse effects can be increased when Moclobemide is combined with Bromperidol.Approved, Investigational
MolindoneThe risk or severity of adverse effects can be increased when Molindone is combined with Bromperidol.Approved
MorphineThe risk or severity of adverse effects can be increased when Morphine is combined with Bromperidol.Approved, Investigational
NabiloneNabilone may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.Approved, Investigational
NalbuphineThe risk or severity of adverse effects can be increased when Nalbuphine is combined with Bromperidol.Approved
NaratriptanThe risk or severity of adverse effects can be increased when Naratriptan is combined with Bromperidol.Approved, Investigational
NefazodoneThe risk or severity of adverse effects can be increased when Bromperidol is combined with Nefazodone.Approved, Withdrawn
NeomycinThe risk or severity of adverse effects can be increased when Bromperidol is combined with Neomycin.Approved, Vet Approved
NicardipineThe serum concentration of Bromperidol can be increased when it is combined with Nicardipine.Approved, Investigational
NiguldipineThe serum concentration of Bromperidol can be increased when it is combined with Niguldipine.Experimental
NimodipineThe serum concentration of Bromperidol can be increased when it is combined with Nimodipine.Approved, Investigational
NisoldipineThe serum concentration of Bromperidol can be increased when it is combined with Nisoldipine.Approved
NitrazepamThe risk or severity of adverse effects can be increased when Nitrazepam is combined with Bromperidol.Approved
NitrendipineThe serum concentration of Bromperidol can be increased when it is combined with Nitrendipine.Approved, Investigational
Nitrous oxideThe risk or severity of adverse effects can be increased when Nitrous oxide is combined with Bromperidol.Approved, Vet Approved
NordazepamThe risk or severity of adverse effects can be increased when Bromperidol is combined with Nordazepam.Approved
NorfluraneThe risk or severity of adverse effects can be increased when Bromperidol is combined with Norflurane.Approved, Investigational
NormethadoneThe risk or severity of adverse effects can be increased when Normethadone is combined with Bromperidol.Approved, Illicit
NortriptylineThe risk or severity of adverse effects can be increased when Nortriptyline is combined with Bromperidol.Approved
OlanzapineThe risk or severity of adverse effects can be increased when Olanzapine is combined with Bromperidol.Approved, Investigational
OlopatadineThe risk or severity of adverse effects can be increased when Olopatadine is combined with Bromperidol.Approved
OmeprazoleThe serum concentration of Bromperidol can be increased when it is combined with Omeprazole.Approved, Investigational, Vet Approved
OndansetronThe risk or severity of adverse effects can be increased when Ondansetron is combined with Bromperidol.Approved
OpiumThe risk or severity of adverse effects can be increased when Opium is combined with Bromperidol.Approved, Illicit
OrphenadrineBromperidol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.Approved
OsanetantThe risk or severity of adverse effects can be increased when Osanetant is combined with Bromperidol.Investigational
OxazepamThe risk or severity of adverse effects can be increased when Oxazepam is combined with Bromperidol.Approved
OxprenololThe risk or severity of adverse effects can be increased when Oxprenolol is combined with Bromperidol.Approved
OxybuprocaineThe risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Bromperidol.Approved, Investigational
OxycodoneThe risk or severity of adverse effects can be increased when Oxycodone is combined with Bromperidol.Approved, Illicit, Investigational
OxymorphoneThe risk or severity of adverse effects can be increased when Oxymorphone is combined with Bromperidol.Approved, Investigational, Vet Approved
PaliperidoneThe risk or severity of adverse effects can be increased when Paliperidone is combined with Bromperidol.Approved
ParaldehydeBromperidol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.Approved, Investigational
ParomomycinThe risk or severity of adverse effects can be increased when Bromperidol is combined with Paromomycin.Approved, Investigational
ParoxetineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Paroxetine.Approved, Investigational
PenfluridolThe risk or severity of adverse effects can be increased when Bromperidol is combined with Penfluridol.Experimental
PentazocineThe risk or severity of adverse effects can be increased when Pentazocine is combined with Bromperidol.Approved, Vet Approved
PentobarbitalThe risk or severity of adverse effects can be increased when Pentobarbital is combined with Bromperidol.Approved, Investigational, Vet Approved
PerampanelPerampanel may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.Approved
PerazineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Perazine.Approved, Investigational
PerospironeThe risk or severity of adverse effects can be increased when Perospirone is combined with Bromperidol.Approved
PerphenazineThe risk or severity of adverse effects can be increased when Perphenazine is combined with Bromperidol.Approved
PethidineThe risk or severity of adverse effects can be increased when Pethidine is combined with Bromperidol.Approved
PhenazocineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Phenazocine.Experimental
PhenelzineThe risk or severity of adverse effects can be increased when Phenelzine is combined with Bromperidol.Approved
PhenibutThe risk or severity of adverse effects can be increased when Bromperidol is combined with Phenibut.Experimental
PhenobarbitalThe risk or severity of adverse effects can be increased when Phenobarbital is combined with Bromperidol.Approved, Investigational
PhenoperidineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Phenoperidine.Experimental
PhenoxyethanolThe risk or severity of adverse effects can be increased when Phenoxyethanol is combined with Bromperidol.Approved
PhentermineBromperidol may decrease the stimulatory activities of Phentermine.Approved, Illicit
PhenytoinThe risk or severity of adverse effects can be increased when Phenytoin is combined with Bromperidol.Approved, Vet Approved
PimozideThe risk or severity of adverse effects can be increased when Pimozide is combined with Bromperidol.Approved
PipamperoneThe risk or severity of adverse effects can be increased when Pipamperone is combined with Bromperidol.Approved, Investigational
PipotiazineThe risk or severity of adverse effects can be increased when Pipotiazine is combined with Bromperidol.Approved, Investigational
PiritramideThe risk or severity of adverse effects can be increased when Bromperidol is combined with Piritramide.Approved, Investigational
PizotifenThe risk or severity of adverse effects can be increased when Pizotifen is combined with Bromperidol.Approved
Polymyxin B SulfateThe risk or severity of adverse effects can be increased when Bromperidol is combined with Polymyxin B Sulfate.Approved, Vet Approved
PomalidomideThe risk or severity of adverse effects can be increased when Pomalidomide is combined with Bromperidol.Approved
PramipexoleBromperidol may increase the sedative activities of Pramipexole.Approved, Investigational
PrazepamThe risk or severity of adverse effects can be increased when Prazepam is combined with Bromperidol.Approved, Illicit
PregabalinThe therapeutic efficacy of Bromperidol can be increased when used in combination with Pregabalin.Approved, Illicit, Investigational
PrilocaineThe risk or severity of adverse effects can be increased when Prilocaine is combined with Bromperidol.Approved
PrimidoneThe risk or severity of adverse effects can be increased when Primidone is combined with Bromperidol.Approved, Vet Approved
ProcaineThe risk or severity of adverse effects can be increased when Procaine is combined with Bromperidol.Approved, Investigational, Vet Approved
ProcarbazineThe risk or severity of adverse effects can be increased when Procarbazine is combined with Bromperidol.Approved, Investigational
ProchlorperazineThe risk or severity of adverse effects can be increased when Prochlorperazine is combined with Bromperidol.Approved, Vet Approved
PromazineThe risk or severity of adverse effects can be increased when Promazine is combined with Bromperidol.Approved, Vet Approved
PromethazineThe risk or severity of adverse effects can be increased when Promethazine is combined with Bromperidol.Approved, Investigational
PropafenoneThe serum concentration of Bromperidol can be increased when it is combined with Propafenone.Approved
PropanididThe risk or severity of adverse effects can be increased when Bromperidol is combined with Propanidid.Experimental
ProparacaineThe risk or severity of adverse effects can be increased when Proparacaine is combined with Bromperidol.Approved, Vet Approved
PropofolThe risk or severity of adverse effects can be increased when Propofol is combined with Bromperidol.Approved, Investigational, Vet Approved
PropoxycaineThe risk or severity of adverse effects can be increased when Propoxycaine is combined with Bromperidol.Approved
ProtriptylineThe risk or severity of adverse effects can be increased when Protriptyline is combined with Bromperidol.Approved
ProxibarbalThe risk or severity of adverse effects can be increased when Bromperidol is combined with Proxibarbal.Experimental
PSD502The risk or severity of adverse effects can be increased when PSD502 is combined with Bromperidol.Investigational
PseudoephedrineThe risk or severity of adverse effects can be increased when Pseudoephedrine is combined with Bromperidol.Approved
PyrantelThe risk or severity of adverse effects can be increased when Bromperidol is combined with Pyrantel.Approved, Vet Approved
QuazepamThe risk or severity of adverse effects can be increased when Quazepam is combined with Bromperidol.Approved, Illicit
QuetiapineThe risk or severity of adverse effects can be increased when Quetiapine is combined with Bromperidol.Approved
QuinagolideThe therapeutic efficacy of Quinagolide can be decreased when used in combination with Bromperidol.Approved, Investigational
QuinisocaineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Quinisocaine.Experimental
RacloprideThe risk or severity of adverse effects can be increased when Bromperidol is combined with Raclopride.Investigational
RamelteonThe risk or severity of adverse effects can be increased when Ramelteon is combined with Bromperidol.Approved, Investigational
RanitidineThe serum concentration of Bromperidol can be increased when it is combined with Ranitidine.Approved
RasagilineThe risk or severity of adverse effects can be increased when Rasagiline is combined with Bromperidol.Approved
RemifentanilThe risk or severity of adverse effects can be increased when Remifentanil is combined with Bromperidol.Approved
RemoxiprideThe risk or severity of adverse effects can be increased when Remoxipride is combined with Bromperidol.Approved, Withdrawn
ReserpineThe risk or severity of adverse effects can be increased when Reserpine is combined with Bromperidol.Approved, Investigational
RifampicinThe serum concentration of Bromperidol can be increased when it is combined with Rifampicin.Approved
RisperidoneThe risk or severity of adverse effects can be increased when Risperidone is combined with Bromperidol.Approved, Investigational
RitanserinThe risk or severity of adverse effects can be increased when Bromperidol is combined with Ritanserin.Investigational
RitobegronBromperidol may decrease the stimulatory activities of Ritobegron.Investigational
RizatriptanThe risk or severity of adverse effects can be increased when Rizatriptan is combined with Bromperidol.Approved
RomifidineThe risk or severity of adverse effects can be increased when Romifidine is combined with Bromperidol.Vet Approved
RopiniroleBromperidol may increase the sedative activities of Ropinirole.Approved, Investigational
RopivacaineThe risk or severity of adverse effects can be increased when Ropivacaine is combined with Bromperidol.Approved
RotigotineBromperidol may increase the sedative activities of Rotigotine.Approved
RufinamideThe risk or severity of adverse effects can be increased when Rufinamide is combined with Bromperidol.Approved
ScopolamineThe risk or severity of adverse effects can be increased when Scopolamine is combined with Bromperidol.Approved, Investigational
SecobarbitalThe risk or severity of adverse effects can be increased when Secobarbital is combined with Bromperidol.Approved, Vet Approved
SelegilineThe risk or severity of adverse effects can be increased when Selegiline is combined with Bromperidol.Approved, Investigational, Vet Approved
SepranoloneThe risk or severity of adverse effects can be increased when Bromperidol is combined with Sepranolone.Investigational
SertindoleThe risk or severity of adverse effects can be increased when Sertindole is combined with Bromperidol.Approved, Investigational, Withdrawn
SertralineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Sertraline.Approved
SevofluraneThe risk or severity of adverse effects can be increased when Sevoflurane is combined with Bromperidol.Approved, Vet Approved
Sodium oxybateSodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.Approved
StiripentolThe risk or severity of adverse effects can be increased when Stiripentol is combined with Bromperidol.Approved
SufentanilThe risk or severity of adverse effects can be increased when Sufentanil is combined with Bromperidol.Approved, Investigational
SulpirideBromperidol may increase the antipsychotic activities of Sulpiride.Approved, Investigational
SultoprideThe risk or severity of adverse effects can be increased when Bromperidol is combined with Sultopride.Experimental
SumatriptanThe risk or severity of adverse effects can be increased when Sumatriptan is combined with Bromperidol.Approved, Investigational
SuvorexantBromperidol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.Approved, Investigational
TandospironeThe risk or severity of adverse effects can be increased when Bromperidol is combined with Tandospirone.Investigational
TapentadolTapentadol may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.Approved
TasimelteonThe risk or severity of adverse effects can be increased when Tasimelteon is combined with Bromperidol.Approved, Investigational
Tedizolid phosphateThe risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Bromperidol.Approved
TemazepamThe risk or severity of adverse effects can be increased when Temazepam is combined with Bromperidol.Approved, Investigational
TetrabenazineThe risk or severity of adverse effects can be increased when Tetrabenazine is combined with Bromperidol.Approved, Investigational
TetracaineThe risk or severity of adverse effects can be increased when Tetracaine is combined with Bromperidol.Approved, Vet Approved
TetracyclineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Tetracycline.Approved, Vet Approved
TetrahydropalmatineThe risk or severity of adverse effects can be increased when Tetrahydropalmatine is combined with Bromperidol.Investigational
TetrandrineThe serum concentration of Bromperidol can be increased when it is combined with Tetrandrine.Experimental
TetrodotoxinThe risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Bromperidol.Investigational
ThalidomideBromperidol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.Approved, Investigational, Withdrawn
ThiamylalThe risk or severity of adverse effects can be increased when Thiamylal is combined with Bromperidol.Approved, Vet Approved
ThiopentalThe risk or severity of adverse effects can be increased when Thiopental is combined with Bromperidol.Approved, Vet Approved
ThioridazineThe risk or severity of adverse effects can be increased when Thioridazine is combined with Bromperidol.Approved, Withdrawn
ThiothixeneThe risk or severity of adverse effects can be increased when Thiothixene is combined with Bromperidol.Approved
TiagabineThe risk or severity of adverse effects can be increased when Tiagabine is combined with Bromperidol.Approved, Investigational
TiaprideThe risk or severity of adverse effects can be increased when Bromperidol is combined with Tiapride.Approved, Investigational
TiletamineThe risk or severity of adverse effects can be increased when Tiletamine is combined with Bromperidol.Vet Approved
TilidineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Tilidine.Experimental
TizanidineThe risk or severity of adverse effects can be increased when Tizanidine is combined with Bromperidol.Approved, Investigational
TolcaponeThe risk or severity of adverse effects can be increased when Tolcapone is combined with Bromperidol.Approved, Withdrawn
TopiramateThe risk or severity of adverse effects can be increased when Topiramate is combined with Bromperidol.Approved
TramadolThe risk or severity of adverse effects can be increased when Tramadol is combined with Bromperidol.Approved, Investigational
TranylcypromineThe risk or severity of adverse effects can be increased when Tranylcypromine is combined with Bromperidol.Approved, Investigational
TrazodoneThe risk or severity of adverse effects can be increased when Trazodone is combined with Bromperidol.Approved, Investigational
TriazolamThe risk or severity of adverse effects can be increased when Triazolam is combined with Bromperidol.Approved, Investigational
Tricaine methanesulfonateThe risk or severity of adverse effects can be increased when Tricaine methanesulfonate is combined with Bromperidol.Vet Approved
TrichloroethyleneThe risk or severity of adverse effects can be increased when Bromperidol is combined with Trichloroethylene.Approved
TrifluoperazineThe risk or severity of adverse effects can be increased when Trifluoperazine is combined with Bromperidol.Approved, Investigational
TrifluperidolThe risk or severity of adverse effects can be increased when Bromperidol is combined with Trifluperidol.Experimental
TriflupromazineThe risk or severity of adverse effects can be increased when Triflupromazine is combined with Bromperidol.Approved, Vet Approved
TrimethadioneThe risk or severity of adverse effects can be increased when Bromperidol is combined with Trimethadione.Approved
TrimipramineThe risk or severity of adverse effects can be increased when Trimipramine is combined with Bromperidol.Approved
TriprolidineThe risk or severity of adverse effects can be increased when Triprolidine is combined with Bromperidol.Approved
Valproic AcidThe risk or severity of adverse effects can be increased when Valproic Acid is combined with Bromperidol.Approved, Investigational
VancomycinThe risk or severity of adverse effects can be increased when Bromperidol is combined with Vancomycin.Approved
VecuroniumThe risk or severity of adverse effects can be increased when Bromperidol is combined with Vecuronium.Approved
VemurafenibThe risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Bromperidol.Approved
VenlafaxineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Venlafaxine.Approved
VeraliprideThe risk or severity of adverse effects can be increased when Bromperidol is combined with Veralipride.Experimental
VerapamilThe serum concentration of Bromperidol can be increased when it is combined with Verapamil.Approved
VigabatrinThe risk or severity of adverse effects can be increased when Vigabatrin is combined with Bromperidol.Approved
VilazodoneThe risk or severity of adverse effects can be increased when Vilazodone is combined with Bromperidol.Approved
VinpocetineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Vinpocetine.Investigational
Vinyl etherThe risk or severity of adverse effects can be increased when Bromperidol is combined with Vinyl ether.Experimental
VortioxetineThe risk or severity of adverse effects can be increased when Vortioxetine is combined with Bromperidol.Approved, Investigational
XenonThe risk or severity of adverse effects can be increased when Bromperidol is combined with Xenon.Experimental
XylazineThe risk or severity of adverse effects can be increased when Xylazine is combined with Bromperidol.Vet Approved
ZaleplonThe risk or severity of adverse effects can be increased when Zaleplon is combined with Bromperidol.Approved, Illicit, Investigational
ZiconotideThe risk or severity of adverse effects can be increased when Ziconotide is combined with Bromperidol.Approved
ZimelidineThe risk or severity of adverse effects can be increased when Bromperidol is combined with Zimelidine.Withdrawn
ZiprasidoneThe risk or severity of adverse effects can be increased when Ziprasidone is combined with Bromperidol.Approved
ZolazepamThe risk or severity of adverse effects can be increased when Zolazepam is combined with Bromperidol.Vet Approved
ZolmitriptanThe risk or severity of adverse effects can be increased when Zolmitriptan is combined with Bromperidol.Approved, Investigational
ZolpidemBromperidol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.Approved
ZonisamideThe risk or severity of adverse effects can be increased when Zonisamide is combined with Bromperidol.Approved, Investigational
ZopicloneThe risk or severity of adverse effects can be increased when Zopiclone is combined with Bromperidol.Approved
ZotepineThe risk or severity of adverse effects can be increased when Zotepine is combined with Bromperidol.Approved, Investigational, Withdrawn
ZuclopenthixolThe risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Bromperidol.Approved, Investigational
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Compound
2448
PubChem Substance
347828647
ChemSpider
2354
BindingDB
81484
ChEBI
31305
ChEMBL
CHEMBL28218
Wikipedia
Bromperidol
ATC Codes
N05AD06 — Bromperidol

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3TerminatedTreatmentAnxiety Disorders / Dementias / Depression / Psychosomatic Disorders / Schizophrenic Disorders1
4Active Not RecruitingTreatmentSchizoaffective Disorders / Schizophrenia and Disorders With Psychotic Features / Schizophrenic Disorders1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.00723 mg/mLALOGPS
logP3.78ALOGPS
logP3.83ChemAxon
logS-4.8ALOGPS
pKa (Strongest Acidic)13.97ChemAxon
pKa (Strongest Basic)8.07ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area40.54 Å2ChemAxon
Rotatable Bond Count6ChemAxon
Refractivity105.41 m3·mol-1ChemAxon
Polarizability41.37 Å3ChemAxon
Number of Rings3ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available
LC-MS/MS Spectrum - LC-ESI-qTof , PositiveLC-MS/MSNot Available
MS/MS Spectrum - , positiveLC-MS/MSsplash10-00xr-3900100000-ff9736b6f93bc161b31c

Taxonomy

Description
This compound belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group.
Kingdom
Organic compounds
Super Class
Organic oxygen compounds
Class
Organooxygen compounds
Sub Class
Carbonyl compounds
Direct Parent
Alkyl-phenylketones
Alternative Parents
Phenylpiperidines / Phenylbutylamines / Butyrophenones / Aryl alkyl ketones / Benzoyl derivatives / Aralkylamines / Fluorobenzenes / Bromobenzenes / Aryl bromides / Aryl fluorides
show 9 more
Substituents
Alkyl-phenylketone / Phenylpiperidine / Butyrophenone / Phenylbutylamine / Benzoyl / Aryl alkyl ketone / Bromobenzene / Fluorobenzene / Halobenzene / Aralkylamine
show 23 more
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
Not Available

Drug created on October 20, 2016 16:14 / Updated on August 02, 2018 06:38